Werewolf Therapeutics, Inc. carried $32.1M in long-term debt against $57.0M in cash and equivalents at the end of fiscal year 2025. Long-term debt was unchanged from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Werewolf Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
HOWL Debt & Cash by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
HOWL Debt & Cash by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25S-4/A | Q3'2510-Q | Q2'2510-Q | Q1'25Filing | Q4'2410-K | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | $32.1M0.0% | $32.1M0.0% | $32.1M0.0% | $32.1M0.0% | $32.1M-19.8% | $32.1M-19.8% | $32.1M-14.6% | $32.1M-18.0% | $40.0M+2.4% | $40.0M |
| Cash & Equivalents | $41.9M-36.3% | $22.0M-71.7% | $46.5M-49.5% | $57.0M-48.6% | $65.7M-46.5% | $77.6M-42.7% | $92.0M-33.9% | $111.0M-17.4% | $122.8M-5.6% | $135.3M-1.6% | $139.2M-5.9% | $134.3M+3.9% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Werewolf Therapeutics, Inc. financials
Frequently Asked Questions
Werewolf Therapeutics, Inc. carried $32.1M in long-term debt against $57.0M in cash and equivalents at the end of fiscal year 2025.
Werewolf Therapeutics, Inc. (HOWL) long-term debt was essentially unchanged year over year, at $32.1M in fiscal year 2025 against $32.1M the year before.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Werewolf Therapeutics, Inc. (HOWL) reported on that line in every period on record.